These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 4073864)

  • 21. In vitro activity of carumonam (RO 17-2301) and twelve other antimicrobials against clinical isolates of Pseudomonas aeruginosa.
    Vurma-Rapp U; Kayser FH
    Eur J Clin Microbiol; 1986 Jun; 5(3):292-6. PubMed ID: 3091365
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacokinetics and metabolism of an intravenously administered penem (Sch 34343) in humans.
    Lin CC; Lim J; Radwanski E; Kim HK; Marco A; Lapiguera A; DiGiore C; Symchowicz S
    Antimicrob Agents Chemother; 1987 Jan; 31(1):84-7. PubMed ID: 3566242
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacokinetics and tissue penetration of enoxacin.
    Wise R; Lockley R; Dent J; Webberly M
    Antimicrob Agents Chemother; 1984 Jul; 26(1):17-9. PubMed ID: 6591851
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacokinetics and tissue penetration of ciprofloxacin.
    Crump B; Wise R; Dent J
    Antimicrob Agents Chemother; 1983 Nov; 24(5):784-6. PubMed ID: 6660852
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacokinetics of carumonam (AMA-1080) in patients with impaired renal function and in those undergoing hemodialysis.
    Konishi K; Suzuki H; Saruta T; Deguchi N; Fugono T
    Antimicrob Agents Chemother; 1991 Jun; 35(6):1048-52. PubMed ID: 1929242
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In vitro activity of carumonam (Ro 17-2301; AMA-1080) versus enteropathogenic and nonfermentative gram-negative rods and Legionella pneumophila.
    Hohl P; von Graevenitz A; Zollinger-Iten J
    Antimicrob Agents Chemother; 1988 Oct; 32(10):1593-4. PubMed ID: 3190188
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Carumonam (Ro 17-2301; AMA-1080) compared with gentamicin for treatment of complicated urinary tract infections.
    Hoepelman AI; Bakker LJ; Verhoef J
    Antimicrob Agents Chemother; 1988 Apr; 32(4):473-6. PubMed ID: 3377459
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A study to determine the pharmacokinetics and inflammatory fluid penetration of two doses of a solid formulation of the hexetil prodrug of a trinem, sanfetrinem (GV 104326).
    Wise R; Andrews JM; Da Ros L; Child J; Mortiboy D
    Antimicrob Agents Chemother; 1997 Aug; 41(8):1761-4. PubMed ID: 9257756
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacokinetics of ceftazidime in serum and suction blister fluid during continuous and intermittent infusions in healthy volunteers.
    Mouton JW; Horrevorts AM; Mulder PG; Prens EP; Michel MF
    Antimicrob Agents Chemother; 1990 Dec; 34(12):2307-11. PubMed ID: 2088186
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vitro and in vivo antibacterial activities of carumonam (AMA-1080), a new N-sulfonated monocyclic beta-lactam antibiotic.
    Imada A; Kondo M; Okonogi K; Yukishige K; Kuno M
    Antimicrob Agents Chemother; 1985 May; 27(5):821-7. PubMed ID: 3874598
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Single-dose pharmacokinetics of the monobactam azthreonam (SQ 26,776) in healthy subjects.
    Swabb EA; Sugerman AA; Platt TB; Pilkiewicz FG; Frantz M
    Antimicrob Agents Chemother; 1982 Jun; 21(6):944-9. PubMed ID: 7202343
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacokinetics of aztreonam in elderly male volunteers.
    Creasey WA; Platt TB; Frantz M; Sugerman AA
    Br J Clin Pharmacol; 1985 Feb; 19(2):233-7. PubMed ID: 4039189
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacokinetics and tissue penetration of temocillin.
    Lockley MR; Brown RM; Wise R
    Drugs; 1985; 29 Suppl 5():106-8. PubMed ID: 4029011
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The pharmacokinetics and tissue penetration of ofloxacin.
    Lockley MR; Wise R; Dent J
    J Antimicrob Chemother; 1984 Dec; 14(6):647-52. PubMed ID: 6596301
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Carumonam versus ceftazidime for urinary tract infections.
    Edelstein H; Oster S; Cassano K; McCabe R
    Antimicrob Agents Chemother; 1988 Jul; 32(7):1031-3. PubMed ID: 3056245
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacokinetics of meropenem in serum and suction blister fluid during continuous and intermittent infusion.
    Mouton JW; Michel MF
    J Antimicrob Chemother; 1991 Dec; 28(6):911-8. PubMed ID: 1816187
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacology of aztreonam after intravenous infusion.
    Scully BE; Swabb EA; Neu HC
    Antimicrob Agents Chemother; 1983 Jul; 24(1):18-22. PubMed ID: 6684898
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of the pharmacokinetics and pharmacodynamic profile of carumonam in cystic fibrosis patients and healthy volunteers.
    Bulitta JB; Duffull SB; Landersdorfer CB; Kinzig M; Holzgrabe U; Stephan U; Drusano GL; Sörgel F
    Diagn Microbiol Infect Dis; 2009 Oct; 65(2):130-41. PubMed ID: 19748423
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The anti-microbial activity, beta-lactamase stability, and disk diffusion susceptibility testing of carumonam (RO 17-2301, AMA-1080), a new monobactam.
    Jones RN; Barry AL; Thornsberry C; Fuchs PC; Packer RR
    Am J Clin Pathol; 1986 Nov; 86(5):608-18. PubMed ID: 3096130
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Difference in blister fluid penetration after single and multiple doses of ceftriaxone.
    LeBel M; Grégoire S; Caron M; Bergeron MG
    Antimicrob Agents Chemother; 1985 Jul; 28(1):123-7. PubMed ID: 4037771
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.